Prevention versus fix-up drugs
4:09–5:12 · 63s
Anthony argues GLP-1 weight-loss drugs should be funded for prevention, not just after heart attacks, laying out the policy tension.
4:09–5:12 · 63s
Anthony argues GLP-1 weight-loss drugs should be funded for prevention, not just after heart attacks, laying out the policy tension.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.